Franzblau S G, Biswas A N, Jenner P, Colston M J
Laboratory Research Branch, Gillis W. Long Hansen's Disease Center, Carville, Louisiana 70721.
Lepr Rev. 1992 Jun;63(2):125-33. doi: 10.5935/0305-7518.19920016.
Two radiorespirometric assays, the BACTEC 460 and Buddemeyer-type 14CO2 detection systems, were evaluated in a double-blind manner for their ability to discriminate between authentic antileprosy agents and inactive compounds. Freshly harvested, nude-mouse derived Mycobacterium leprae were incubated in axenic media in the presence of coded test solutions prepared in a remote laboratory. Activity was assessed by comparing the rate of 14CO2 evolution from [1-14C]palmitic acid to controls. Breaking the code revealed that both systems demonstrated a dose response to ethionamide, pefloxacin and rifampicin as well as sensitivity to dapsone. Most of the water, ethanol, sucrose, dabsyl chloride and riboflavin negative-control samples failed to effect a significant reduction in radiorespirometric activity. This study confirms the ability of the radiorespirometric assays to function as a primary drug screening system in leprosy.
采用双盲方式对两种放射性呼吸测定法(BACTEC 460和Buddemeyer型14CO2检测系统)鉴别抗麻风病药物与非活性化合物的能力进行了评估。将刚收获的源自裸鼠的麻风分枝杆菌在无菌培养基中与在远程实验室配制的编码测试溶液一起孵育。通过比较[1-14C]棕榈酸释放14CO2的速率与对照来评估活性。解码后发现,这两种系统对乙硫异烟胺、培氟沙星和利福平均表现出剂量反应,对氨苯砜也具有敏感性。大多数水、乙醇、蔗糖、丹磺酰氯和核黄素阴性对照样品未能显著降低放射性呼吸活性。本研究证实了放射性呼吸测定法作为麻风病初级药物筛选系统的能力。